Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 13.15 billion as of June 13, 2025. Its market cap has decreased by -38.30% in one year.

Market Cap

13.15B

Enterprise Value

11.25B

Revenue

34.23M

Ranking

n/a

PE Ratio

n/a

Stock Price

102.50

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 13.15B, an increase of 48.28%. That is a compound annual growth rate of 4.83%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	12.77B	-11.11%
Dec 31, 2024	14.37B	-31.28%
Dec 29, 2023	20.91B	-42.13%
Dec 30, 2022	36.13B	16.16%
Dec 30, 2021	31.10B	17.15%
Dec 31, 2020	26.55B	222.07%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	180.96B
Caliway Biopharmaceuticals	149.82B
Bora Pharmaceuticals Co., LTD.	83.79B
Lotus Pharmaceutical	60.82B
Polaris Group	30.66B
Center Laboratories	29.36B
Lumosa Therapeutics	28.02B
Oneness Biotech	27.36B

Market Cap Rankings